Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2048706 | FEBS Letters | 2011 | 5 Pages |
Dihydrofolate reductase (DHFR) is a well-studied drug target and a paradigm for understanding enzyme catalysis. Preparation of pure DHFR samples, in defined ligand-bound states, is a prerequisite for in vitro studies and drug discovery efforts. We use NMR spectroscopy to monitor ligand content of human and Escherichia coli DHFR (ecDHFR), which bind different co-purifying ligands during expression in bacteria. An alternate purification strategy yields highly pure DHFR complexes, containing only the desired ligands, in the quantities required for structural studies. Interestingly, ecDHFR is bound to endogenous THF while human DHFR is bound to NADP. Consistent with these findings, a designed “humanized” mutant of ecDHFR switches binding specificity in the cell.
► NMR data show that endogenous ligands copurify with DHFR expressed in bacterial cells. ► Human DHFR is preferentially bound to NADP, and Escherichia coli DHFR is bound to THF. ► An E. coli DHFR mutant switches binding specificities to resemble the human enzyme. ► We describe purification schemes to obtain DHFR samples with only desired ligands.